Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014

4th Annual Pharma R&D Asia Congress 2014

27 Feb 2014 - 28 Feb 2014 - Shanghai, China

Bookmark and Share

The booming growth of research and development activities in Asia and Asia Pacific regions has advanced the opportunity for business success. Industry leaders believe that the Asian market will overtake the US by 2020. Our conference will bring together industry leaders to discuss the potential and future of the R&D industry. Our exclusive networking sessions will offer opportunities to meet with potential partners and form unique business relationships.

Expert speakers will discuss strategies to advance research and development activities in Asia. They will offer insights into the importance of collaborations between eastern and western countries for advancing global drug development. Topics will also cover methods to choose correct outsourcing partners for business needs, attaining successful mergers and acquisitions and opportunities for multi-national companies in emerging markets.

Confirmed Speakers Include:

·         Yariv Hefez, VP, Merck, Switzerland

·         Beverly Lui, Director, Amgen, China

·         Jian Li, Director, Global R&D Sanofi, China

·         Yuan-Hua Ding, Senior Director, Pfizer Worldwide R&D, USA

·         Simon McErlane, Senior Medical, Takeda Development Center Asia, Singapore

 To view full list of speakers, click here.

The event will provide the opportunity for networking and knowledge sharing in the expanding clinical market in Asia and Asia Pacific regions. Over the two days the event will attract over 150 senior-level international decision makers working in discovery, R&D, translational sciences, medical affairs and outsourcing & partnerships from pharma and biotech companies in Asia, Australia, the USA and Europe.

To download agenda, please click here.

Please contact Freda Shi at +65 6570 2208 or email to express your interest today!

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos